Neuroendocrine tumors (NETs) are rare neoplasms characterized by overexpression of
somatostatin receptors (SSTRs). Functional imaging plays a crucial role in management of …

Radiolabeled somatostatin analogs represent valuable tools for both in vivo diagnosis and
therapy of neuroendocrine tumors (NETs) because of the frequent tumoral overexpression of …

In patients with neuroendocrine tumours (NETs), a combination of morphological imaging
and nuclear medicine techniques is mandatory for primary tumour visualization, staging and …

Purpose Somatostatin receptor (SSTR) PET has become a mainstay in the diagnosis of
neuroendocrine tumors (NETs) and for selecting patients for SSTR-based therapy; however …

Overexpression of somatostatin receptors (SSTRs) in patients with neuroendocrine
neoplasms (NENs) is used for both diagnosis and treatment. Receptor density may reflect …

Neuroendocrine tumors (NETs) are rare group of neoplasms arising from nervous and
endocrine systems. Somatostatin analogue imaging is a functional imaging modality of …

Simple Summary Neuroendocrine neoplasms (NENs) are rare and heterogeneous tumors,
presenting in often challenging clinical scenarios, and require multidisciplinary discussion …

Neuroendocrine neoplasms (NEN) are rare and heterogeneous tumors, originating mostly
from the gastro-entero-pancreatic (GEP) tract followed by the lungs. Multidisciplinary …

Theranostics of neuroendocrine neoplasms (NENs) based on molecular imaging using
receptor positron emission tomography/computed tomography (PET/CT) with 68Ga-labeled …

Theranostics and its principles: pre-treatment selection of patients who are most likely to
benefit from treatment by the use of a related, specific diagnostic test are integral to the …